Orchestra BioMed Holdings (OBIO) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$368.8 million.
- Orchestra BioMed Holdings' Retained Earnings fell 2556.86% to -$368.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$368.8 million, marking a year-over-year decrease of 2556.86%. This contributed to the annual value of -$309.9 million for FY2024, which is 2452.2% down from last year.
- Per Orchestra BioMed Holdings' latest filing, its Retained Earnings stood at -$368.8 million for Q3 2025, which was down 2556.86% from -$348.0 million recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Retained Earnings ranged from a high of -$4.4 million in Q1 2022 and a low of -$368.8 million during Q3 2025
- Moreover, its 4-year median value for Retained Earnings was -$248.9 million (2023), whereas its average is -$221.6 million.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 470980.0% in 2023, then tumbled by 2443.99% in 2024.
- Orchestra BioMed Holdings' Retained Earnings (Quarter) stood at -$199.7 million in 2022, then decreased by 24.59% to -$248.9 million in 2023, then dropped by 24.52% to -$309.9 million in 2024, then dropped by 19.02% to -$368.8 million in 2025.
- Its last three reported values are -$368.8 million in Q3 2025, -$348.0 million for Q2 2025, and -$328.6 million during Q1 2025.